Cardama Alfonso Quintas

CIK 00017601042 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001760104

Recent Transactions

50 trades

Award
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2025-01-22$4.37/sh+125,000→ 125,000 total
Award
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2024-01-24$3.06/sh+60,000→ 60,000 total
Award
Foghorn Therapeutics Inc.$FHTX
Stock Options (Right to buy)
2023-09-11$7.57/sh+272,000→ 272,000 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−42,346→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Restricted Stock Unit
2023-06-01−11,775→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Restricted Stock Unit
2023-06-01−9,549→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Common Stock
2023-06-01−109,459→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−90,720→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Restricted Stock Unit
2023-06-01−6,489→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−114,700→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−70,649→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Restricted Stock Unit
2023-06-01−1,409→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−31,582→ 0 total
Award
TCR2 THERAPEUTICS INC.
Restricted Stock Unit (Right to Buy)
2022-12-15+11,775→ 11,775 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2022-12-15+70,649→ 70,649 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2022-12-13$1.06/sh−4,752→ 109,459 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2022-12-12$1.10/sh−4,586→ 114,211 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2022-12-09$1.13/sh−4,461→ 118,797 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2022-12-08$1.26/sh−4,014→ 123,258 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2022-12-07$1.28/sh−3,928→ 127,272 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2022-12-06$1.33/sh−3,778→ 131,200 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2022-12-05$1.37/sh−3,686→ 134,978 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2022-12-02$1.39/sh−3,636→ 138,664 total
Exercise/Conversion
TCR2 THERAPEUTICS INC.
Restricted Stock Unit
2022-12-01+17,545→ 6,489 total
Exercise/Conversion
TCR2 THERAPEUTICS INC.
Restricted Stock Unit
2022-12-01+8,815→ 9,549 total
Exercise/Conversion
TCR2 THERAPEUTICS INC.
Restricted Stock Unit
2022-12-01+69,025→ 1,409 total
Exercise/Conversion
TCR2 THERAPEUTICS INC.
Common Stock
2022-12-01+95,385→ 142,300 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (right to buy)
2022-11-17−205,503→ 0 total
Award
TCR2 THERAPEUTICS INC.
Restricted Stock Unit (right to buy)
2022-11-17+1,933→ 1,933 total
Award
TCR2 THERAPEUTICS INC.
Restricted Stock Unit (right to buy)
2022-11-17+1,103→ 1,103 total
Award
TCR2 THERAPEUTICS INC.
Restricted Stock Unit (right to buy)
2022-11-17+22,931→ 22,931 total
Award
TCR2 THERAPEUTICS INC.
Restricted Stock Unit (right to buy)
2022-11-17+816→ 816 total
Award
TCR2 THERAPEUTICS INC.
Restricted Stock Unit (right to buy)
2022-11-17+17,548→ 17,548 total
Award
TCR2 THERAPEUTICS INC.
Restricted Stock Unit (right to buy)
2022-11-17+68,501→ 68,501 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (right to buy)
2022-11-17−68,792→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (right to buy)
2022-11-17−3,308→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (right to buy)
2022-11-17−4,486→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (right to buy)
2022-11-17−96,514→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (right to buy)
2022-11-17−5,799→ 0 total
Exercise/Conversion
TCR2 THERAPEUTICS INC.
Common Stock
2021-12-09$0.74/sh+43,000→ 46,915 total
Exercise/Conversion
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2021-12-09$0.74/sh+43,000→ 31,582 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2021-12-09+114,700→ 114,700 total
Award
TCR2 THERAPEUTICS INC.
Common Stock
2021-08-31$14.26/sh+164→ 3,915 total
Award
TCR2 THERAPEUTICS INC.
Common Stock
2021-02-28$16.12/sh+708→ 3,751 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2020-12-10+101,000→ 101,000 total
Award
TCR2 THERAPEUTICS INC.
Common Stock
2020-08-31$10.10/sh+1,118→ 3,043 total
Award
TCR2 THERAPEUTICS INC.
Common Stock
2020-02-28$10.10/sh+1,082→ 1,925 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2019-12-19−72,100→ 72,100 total
Award
TCR2 THERAPEUTICS INC.
Common Stock
2019-08-30$12.75/sh+843→ 843 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2019-04-11+211,302→ 211,302 total

Companies

Recent Filings

Address

500 TECHNOLOGY SQUARE SUITE 700

CAMBRIDGE, MA, 02139

View on SEC.gov